Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Asthma

Free Subscription 20.04.2026 2 Ann Allergy Asthma Immunol 1 Arch Dis Child 2 Arerugi 2 Chest 1 Clin Exp Allergy 7 J Asthma 1 J Immunol 1 Pediatr Pulmonol 1 PLoS One 1 Respir Med 2 Respir Res 1 Respiration 4 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Allergy Asthma Immunol

1. COUILLARD S, Petousi N, Ramakrishnan S, Valle R, et al
   Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asth
   Ann Allergy Asthma Immunol. 2026 Apr 10:S1081-1206(26)00150.
   PubMed         Abstract available
   
   
2. ABD AE, Trottier H, Tse SM, Masse B, et al
   Impact of vitamin D status and supplementation on exploratory inflammatory biomarkers in preschoolers with asthma.
   Ann Allergy Asthma Immunol. 2026 Apr 9:S1081-1206(26)00128.
   PubMed         Abstract available
   
   

   
   Arch Dis Child

3. MOHAMMED ABDUL WAJID L, Saglani S, Nagakumar P, Heath G, et al
   Exploring health professional views of management for preschool wheeze: a qualitative study.
   Arch Dis Child. 2026;111:444-448.
   PubMed         Abstract available
   
   

   
   Arerugi

4. HARIGANE R, Rikimaru M, Kume H
   [A CASE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS THAT DEVELOPED FROM DE NOVO SENSITIZATION IN A STABLE NON-ATOPIC ASTHMA, DIAGNOSED BY COMPUTED TOMOGRAPHY].
   Arerugi. 2026;75:153-158.
   PubMed         Abstract available
   
   
5. ITOGA M, Oyama S, Nunomura Y, Fukushima T, et al
   [DIAGNOSIS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS BASED ON RENAL PATHOLOGICAL FINDINGS WITHOUT ASTHMA].
   Arerugi. 2026;75:147-152.
   PubMed         Abstract available
   
   

   
   Chest

6. GRAVES JM, Krings JG
   Payer-Driven Inhaler Switching: An Underrecognized Threat to Asthma and COPD Care.
   Chest. 2026;169:867-869.
   PubMed        
   
   
7. PEIRCE AM, Hogan CK, Weinstein JB, Seelye SM, et al
   Clinician Views on Inhaler Substitution in the Veterans Health Administration.
   Chest. 2026;169:1039-1050.
   PubMed         Abstract available
   
   

   
   Clin Exp Allergy

8. KOBAYASHI Y, Ho QD, Le NKT, Khuc LTT, et al
   The Clinical Value of Measuring Nasal Nitric Oxide in Addition to Exhaled Nitric Oxide in Asthma Associated With Eosinophilic Chronic Rhinosinusitis.
   Clin Exp Allergy. 2026 Apr 16. doi: 10.1111/cea.70305.
   PubMed        
   
   

   
   J Asthma

9. LI M, Xu Y, Dai K, Tao L, et al
   Exogenous Compounds and Confounding Variables: Re-evaluating the Diagnostic Accuracy of Breath Metabolomics in Asthma and COPD.
   J Asthma. 2026 Apr 12:1-2. doi: 10.1080/02770903.2026.2654595.
   PubMed        
   
   
10. KALLIERI M, Papadopoulos NG, Zervas E, Exarchos K, et al
    Geographical variability in severe asthma: comparison of patients' characteristics between national, regional and international cohorts in ISAR.
    J Asthma. 2026 Apr 12:1-16. doi: 10.1080/02770903.2026.2654601.
    PubMed         Abstract available
    
    
11. BOZEK A, Miodonska M, Sadowska D, Zalejska Fijolka J, et al
    Three years treatment with HDM allergen immunotherapy, omalizumab, or combination therapy in allergic asthma: clinical outcomes and biomarkers.
    J Asthma. 2026 Apr 15:1-18. doi: 10.1080/02770903.2026.2660096.
    PubMed         Abstract available
    
    
12. XU X, Gao S, Huang Z, Mao Y, et al
    Emerging Trends and Research Frontiers in Refractory Asthma: A Comprehensive Bibliometric Analysis from 2004 to 2025.
    J Asthma. 2026 Apr 15:1-13. doi: 10.1080/02770903.2026.2660324.
    PubMed         Abstract available
    
    
13. MATSUNO O
    Baseline Blood Eosinophil Count Does Not Predict Short-Term Changes in Oscillometric Parameters in Steroid-Naive Asthma.
    J Asthma. 2026 Apr 17:1-13. doi: 10.1080/02770903.2026.2660094.
    PubMed         Abstract available
    
    
14. ALAMI A, Little J, Zwerling AA, Abdul SA, et al
    Self-Perceived Mental Health Among Canadian Adolescents and Young Adults with Asthma: Insights from a National Cross-sectional Study.
    J Asthma. 2026 Apr 17:1-12. doi: 10.1080/02770903.2026.2660321.
    PubMed         Abstract available
    
    
15. SAINT-FLEUR AL, Cohen RT, Trivedi M, Sawicki GS, et al
    Clinician Perspectives on the Discontinuation of Brand Name Flovent in Pediatric Asthma Care.
    J Asthma. 2026 Apr 17:1-11. doi: 10.1080/02770903.2026.2660098.
    PubMed         Abstract available
    
    

    
    J Immunol

16. SUI S, Yang L, Ji D, Guo J, et al
    miR-449b-5p from adipose-derived mesenchymal stem cell-derived exosomes targets IGF1R to alleviate airway inflammation and improve airway smooth muscle cell dysfunction in children with asthma.
    J Immunol. 2026;215:vkaf376.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

17. GABBAY JM, Bajaj BVM, Levano SR, Wu AC, et al
    Predicting Pediatric Asthma Readmissions Through Machine Learning: Performance With a National Administrative Database.
    Pediatr Pulmonol. 2026;61:e71624.
    PubMed         Abstract available
    
    

    
    PLoS One

18. LIU L, Sun Y, Wang Y, Xie X, et al
    Bioinformatics analysis and qRT-PCR validation of iron metabolism-related genes in pediatric asthma.
    PLoS One. 2026;21:e0346063.
    PubMed         Abstract available
    
    

    
    Respir Med

19. HUANG H, Liang H, Wang J, Gong Z, et al
    Type 2 biomarkers outperform asthma-COPD overlap definitions in predicting clinical outcomes in COPD patients initiating triple therapy: A prospective cohort study.
    Respir Med. 2026;257:108825.
    PubMed         Abstract available
    
    

    
    Respir Res

20. NIU W, Huang J, Hu Y, Tang G, et al
    Short-term effects of air pollutants on asthma hospitalizations in a megacity in North China (2016-2021): a time-series study.
    Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03620.
    PubMed        
    
    
21. HUGO T, Harper AR, Leander J, Gardiner P, et al
    Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).
    Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03613.
    PubMed        
    
    

    
    Respiration

22. SCIOSCIA G, Quarato CMI, Benfante A, Caiaffa MF, et al
    Sex comparison in clinical presentation, response, and remission in severe type-2 asthma patients treated with biologics: a real-world analysis from the "Southern Italy Network on Severe Asthma Therapy".
    Respiration. 2026 Apr 10:1-18. doi: 10.1159/000550911.
    PubMed         Abstract available
    
    

    
    Thorax

23. WILSON AM, Musgrave SD, Smith JR, Noble M, et al
    At-risk registers integrated into primary care to stop asthma crises in the UK: cluster randomised controlled trial with economic evaluation.
    Thorax. 2026 Apr 15:thorax-2025-223973. doi: 10.1136/thorax-2025-223973.
    PubMed         Abstract available
    
    
24. LAI CC, Chen CH, Wang YH, Wang CY, et al
    Association between overuse of short-acting beta2-agonists and the risk of major adverse cardiovascular events among patients with asthma.
    Thorax. 2026 Apr 15:thorax-2024-222204. doi: 10.1136/thorax-2024-222204.
    PubMed         Abstract available
    
    
25. POPOVIC M, Maule M, Moccia C, Isaevska E, et al
    Maternal eating disorders and respiratory outcomes in childhood: findings from the EU Child Cohort Network.
    Thorax. 2026;81:464-473.
    PubMed         Abstract available
    
    
26. NAESILLA N, Quint JK, Zuber V
    Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence.
    Thorax. 2026;81:447-456.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum